ATC code H05 Calcium homeostasis is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup H05 is part of the anatomical group H Systemic hormonal preparations, excluding sex hormones and insulins.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QH05.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
H05A Parathyroid hormones and analogues
editH05AA Parathyroid hormones and analogues
edit- H05AA01 Parathyroid gland extract
- H05AA02 Teriparatide
- H05AA03 Parathyroid hormone
- H05AA04 Abaloparatide
- H05AA05 Palopegteriparatide
H05B Anti-parathyroid agents
editH05BA Calcitonin preparations
edit- H05BA01 Calcitonin (salmon synthetic)
- H05BA02 Calcitonin (pork natural)
- H05BA03 Calcitonin (human synthetic)
- H05BA04 Elcatonin
H05BX Other anti-parathyroid agents
edit- H05BX01 Cinacalcet
- H05BX02 Paricalcitol
- H05BX03 Doxercalciferol
- H05BX04 Etelcalcetide
- H05BX05 Calcifediol
- H05BX06 Evocalcet
References
edit- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code H05". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QH05". WHO Collaborating Centre for Drug Statistics Methodology.